Clinical Trial

Normalizing Antibody Detection in First-void Urine

Study acronym: URINORM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to develop robust analytical protocols for the monitoring of vaccine induced immunity against the Human Papillomavirus (HPV) in first-void urine samples and to examine fluctuations of urinary HPV-specific antibodies and potential normalization markers in different cohorts.
Trial Details
NCT Number NCT06582654
Lead Sponsor Universiteit Antwerpen
Collaborators: University Hospital, Antwerp
Conditions Human Papillomavirus Infection
Enrollment 150 participants
Start Date 2023-12-07
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-03